… ProQR to Present at Three Scientific Conferences in April … and CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … K. Koenekoop, MD, PhD, principle investigator of the ProQR Phase 1/2 STELLAR clinical trial of QR-421a and …
… ProQR to Present at the JMP Life Sciences Conference LEIDEN, the Netherlands, June 14, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … am ET, Gerard Platenburg, Chief Innovation Officer of ProQR, will participate in an analyst led fireside chat …
… ProQR to Present at the Chardan Genetic Medicines Conference … LEIDEN, the Netherlands, Oct. 02, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Presenter : Gerard Platenburg, chief innovation officer of ProQR Presentation : Tuesday, October 9, 2018 at 8:00 am ET …
… ProQR Prices $90 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated … of $6.50 per share. All of the shares are being offered by ProQR. In addition, ProQR has granted the underwriters a …
… ProQR Prices $90.6 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical … share. All of the shares are being offered by ProQR. The offering is expected to close on September 11, …
… ProQR Announces Upcoming Scientific Presentations at ASGCT … (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … said Gerard Platenburg, Chief Scientific Officer of ProQR. "The data we will present at ASGCT and TIDES further …
… ProQR Announces R&D Day and Provides Update on Innovation Portfolio First … NY LEIDEN, Netherlands, Nov. 30, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … to the future of medicine,” said Daniel de Boer, CEO of ProQR. “Our innovation platform has been very efficient and …
… ProQR Prices $50 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical … of $5.50 per share. All of the shares are being offered by ProQR. In addition, ProQR has granted the underwriters a …